FDA Guidance on CT Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA issued this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.
Related Education Resources.
All ResourcesVideo on eTMF Requirements provided by Steve Jacobs, Chairman at Global BioPharm Solutions.
Topics: Pharma Industry, Strategic Planning
Video
Members
Expanded Access: Past, Present and Future Improvements
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Position Paper
Free
Leadership Lessons for Re-Entry
Topics: Leadership, Management
Webinar
Free
